作者
László Gellér, Zoltán Salló, Levente Molnár, Tamás Tahin, Emin Evren Özcan, Valentina Kutyifa, István Osztheimer, Szabolcs Szilágyi, Nándor Szegedi, Pál Ábrahám, Astrid Apor, Klaudia Vivien Nagy, Annamária Kosztin, Dávid Becker, Szilvia Herczeg, Endre Zima, Béla Merkely
发表日期
2019/8/1
期刊
EP Europace
卷号
21
期号
8
页码范围
1237-1245
出版商
Oxford University Press
简介
Aims
The aim of our study was to investigate the long-term efficacy and safety of transseptal endocardial left ventricular lead implantation (TELVLI).
Methods and results
Transseptal endocardial left ventricular lead implantation was performed in 54 patients (44 men, median age 69, New York Heart Association III–IV stage) between 2007 and 2017 in a single centre. In 36 cases, the transseptal puncture (TP) was performed via the femoral vein, and in 18 cases, the TP and also the left ventricular (LV) lead placement were performed via the subclavian vein. An electrophysiological deflectable catheter was used to reach the LV wall through the dilated TP hole. The LV lead implantation was successful in all patients. A total of 54 patients were followed up for a median of 29 months [interquartile range (IQR) 8–40 months], the maximum follow-up time was 94 months. Significant …
学术搜索中的文章
L Gellér, Z Salló, L Molnár, T Tahin, EE Özcan… - EP Europace, 2019